Cargando…
Communication strategies for rare cancers: a systematic review protocol
BACKGROUND: Rare cancers comprise almost a quarter of all cancers in Europe, and patients generally have poorer outcomes than those suffering from more common cancers. This is attributed in part to a general lack of knowledge and awareness of rare cancers. This review aims to examine the communicati...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477728/ https://www.ncbi.nlm.nih.gov/pubmed/31014400 http://dx.doi.org/10.1186/s13643-019-1017-5 |
_version_ | 1783413067892129792 |
---|---|
author | Bell, Catherine Kerr, Katie Moore, Kerry McShane, Charlene Anderson, Lesley McKnight, Amy Jayne McAneney, Helen |
author_facet | Bell, Catherine Kerr, Katie Moore, Kerry McShane, Charlene Anderson, Lesley McKnight, Amy Jayne McAneney, Helen |
author_sort | Bell, Catherine |
collection | PubMed |
description | BACKGROUND: Rare cancers comprise almost a quarter of all cancers in Europe, and patients generally have poorer outcomes than those suffering from more common cancers. This is attributed in part to a general lack of knowledge and awareness of rare cancers. This review aims to examine the communication strategies being used throughout the world to inform on rare cancers and to highlight any opportunities for improvement. METHODS: A systematic review of literature published in English prior to November 2018 will be conducted, screening articles from the electronic databases MEDLINE, PubMed, EMBASE, Web of Science, PsycINFO, CINAHL Plus and the Cochrane Database of Systematic Reviews. Grey literature databases (GreyLit, OpenGrey) will also be searched in order to screen for any unpublished works. As well as primary literature, reference lists will be examined via forward and reverse citation screening. The review will be reported using the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA). Titles and abstracts will first be examined for eligibility, with remaining studies undergoing a full-text screening before being included in the final review. Individual studies will be screened for bias, and a meta-analysis performed provided there is enough data. If insufficient homogenous literature exists, a narrative summary of the literature will be produced. DISCUSSION: Despite the broad topic and width of study type that will be considered, this review hopes to provide a reflective summary of the communication strategies available for people living with and working with rare cancer. It aims to reveal any gaps in the resources available, to contribute to the long-term improvement of diagnosis and management of rare cancers. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42018099784 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13643-019-1017-5) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6477728 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-64777282019-05-01 Communication strategies for rare cancers: a systematic review protocol Bell, Catherine Kerr, Katie Moore, Kerry McShane, Charlene Anderson, Lesley McKnight, Amy Jayne McAneney, Helen Syst Rev Protocol BACKGROUND: Rare cancers comprise almost a quarter of all cancers in Europe, and patients generally have poorer outcomes than those suffering from more common cancers. This is attributed in part to a general lack of knowledge and awareness of rare cancers. This review aims to examine the communication strategies being used throughout the world to inform on rare cancers and to highlight any opportunities for improvement. METHODS: A systematic review of literature published in English prior to November 2018 will be conducted, screening articles from the electronic databases MEDLINE, PubMed, EMBASE, Web of Science, PsycINFO, CINAHL Plus and the Cochrane Database of Systematic Reviews. Grey literature databases (GreyLit, OpenGrey) will also be searched in order to screen for any unpublished works. As well as primary literature, reference lists will be examined via forward and reverse citation screening. The review will be reported using the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA). Titles and abstracts will first be examined for eligibility, with remaining studies undergoing a full-text screening before being included in the final review. Individual studies will be screened for bias, and a meta-analysis performed provided there is enough data. If insufficient homogenous literature exists, a narrative summary of the literature will be produced. DISCUSSION: Despite the broad topic and width of study type that will be considered, this review hopes to provide a reflective summary of the communication strategies available for people living with and working with rare cancer. It aims to reveal any gaps in the resources available, to contribute to the long-term improvement of diagnosis and management of rare cancers. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42018099784 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13643-019-1017-5) contains supplementary material, which is available to authorized users. BioMed Central 2019-04-23 /pmc/articles/PMC6477728/ /pubmed/31014400 http://dx.doi.org/10.1186/s13643-019-1017-5 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Protocol Bell, Catherine Kerr, Katie Moore, Kerry McShane, Charlene Anderson, Lesley McKnight, Amy Jayne McAneney, Helen Communication strategies for rare cancers: a systematic review protocol |
title | Communication strategies for rare cancers: a systematic review protocol |
title_full | Communication strategies for rare cancers: a systematic review protocol |
title_fullStr | Communication strategies for rare cancers: a systematic review protocol |
title_full_unstemmed | Communication strategies for rare cancers: a systematic review protocol |
title_short | Communication strategies for rare cancers: a systematic review protocol |
title_sort | communication strategies for rare cancers: a systematic review protocol |
topic | Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477728/ https://www.ncbi.nlm.nih.gov/pubmed/31014400 http://dx.doi.org/10.1186/s13643-019-1017-5 |
work_keys_str_mv | AT bellcatherine communicationstrategiesforrarecancersasystematicreviewprotocol AT kerrkatie communicationstrategiesforrarecancersasystematicreviewprotocol AT moorekerry communicationstrategiesforrarecancersasystematicreviewprotocol AT mcshanecharlene communicationstrategiesforrarecancersasystematicreviewprotocol AT andersonlesley communicationstrategiesforrarecancersasystematicreviewprotocol AT mcknightamyjayne communicationstrategiesforrarecancersasystematicreviewprotocol AT mcaneneyhelen communicationstrategiesforrarecancersasystematicreviewprotocol |